Social Media Press Releases
RSSShowing Press Releases with Tag: asthma
5/01/2006
MedImmune Presents New Data From Pediatric Studies With FluMist(R) At Pediatric Academic Societies Annual Meeting
» read more12/27/2005
FDA Approves MedImmune’s State-of-the-Art Influenza Vaccine Manufacturing Facility
» read more12/12/2005
Preliminary Data from CAIV-T Pivotal Phase 3 Trial Demonstrate Clinical Efficacy Over Flu Shot in Head-to-Head Influenza Study
» read more12/07/2005
MedImmune Expands Patent Estate for Reverse Genetics with New Rights from Mount Sinai School of Medicine
» read more9/19/2005
MedImmune Submits Refrigerator-Stable Formulation of FluMist(R) to FDA for Approval in Healthy Individuals 5 to 49 Years of Age
» read more9/01/2005
CDC’s Recommended Influenza Prioritization Schedule Highlights FluMist(R) as an Option to Protect Healthy People 5-49 Years of Age
» read more5/25/2005
Preclinical Data Support Link Between IL-9 and Airway Hyperresponsiveness Associated With Asthma
» read more- Previous «
- 1
- 2
- 3
- 4
